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KEYWORDS Summary Glutaric acidemia type I (GA-I) is an inherited metabolic disease characterized
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by accumulation of glutaric acid (GA) and seizures. Considering that seizures are precipitated
by common infections in children with GA-I, we investigated whether lipopolysaccharide (LPS)
modiﬁes GA-induced electrographic and neurochemical alterations in 21 days-old rats. The
effect of LPS on convulsive behavior and electroencephalographic (EEG) alterations induced by
GA (0.13; 0.4; 1.3mol/striatum) was determined in freely moving rats. After EEG recordings,
f interleukin 1 (IL-1) in GA-injected striatum. The injection of
Seizures
we measured the levels o
LPS (2mg/kg; i.p.) 6 h before of GA administration, reduced the latency and increased the
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duration of seizures induced by GA (1.3mol/site). In addition, LPS administration increased
IL-1 striatal levels, which positively correlated with total time in seizures. The intrastriatal
injection of an IL-1 antibody (200 ng/2l) prevented the facilitation of GA-induced seizures by
LPS. These data suggest that inﬂammatory processes during critical periods of development may
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evaluation, the animals were sacriﬁced by decapitation to deter-
mine IL-1 levels in the injected striatum.
Since LPS administration 6 h before GA intrastriatal injection
ss und
decrease GA-induced seizure
© 2010 Elsevier B.V.
Glutaric acidemia type I (GA-I) is an inherited neu-
rodegenerative disease caused by deﬁciency of the
mitochondrial enzyme glutaryl-CoA dehydrogenase (GCDH;
EC 1.3.99.7), which is involved in the metabolism of L-lysine,
L-hydroxylysine and L-tryptophan. Affected patients accu-
mulate majorly glutaric acid (GA), 3-hydroxyglutaric acid
(3-OH-GA) and glutaconic acid in the body ﬂuids (Goodman
et al., 1977). Clinical manifestations of GA-I are predomi-
nantly neurological, including convulsions, especially after
encephalophatic crises, which are accompanied by bilateral
and irreversible destruction of susceptible brain regions,
i.e. striatum (Hoffmann and Zschocke, 1999). Furthermore,
neurological crises are typically precipitated by common
infection, febrile illness and after routine immunization,
suggesting a role of inﬂammatory mediators in this organic
aciduria (Hoffmann and Zschocke, 1999). A substantial
body of evidence indicates that brief systemic inﬂamma-
tion during critical periods of development may result in
long-lasting cerebral and peripheral vulnerability (Hagberg
and Mallard, 2005). For instance, it has been shown that
rats injected at postnatal day 14 (P14) with LPS are more
susceptible to seizures induced by lithium—pilocarpine,
kainic acid (KA) and pentylenetetrazole (PTZ; Galic et al.,
2008).
The inﬂammatory response brought about by LPS is
characterized by innate immune system activation and
production of proinﬂammatory mediators, such as tumor
necrosis factor (TNF) and IL-1 (Cohen, 2002). These
proinﬂammatory cytokines are now accepted as bona ﬁde
modulators of both normal and abnormal neuronal trans-
mission within the brain (Merrill, 1992).
In this context, previous reports have shown that GA-I
metabolites interfere with astrocytic glutamatergic trans-
porters (Porciúncula et al., 2004) and provide evidence that
astrocyte proliferation is associated with mitochondrial dys-
function and oxidative stress (Olivera et al., 2008). In line of
this view, the appearance of such newborn astrocytes may
underlie the subsequent development of gliosis that disrupt
brain development, perhaps contributing for the establish-
ment of neurological deﬁcits in GA-I patients (Goodman and
Frerman, 2001). In addition, it has been shown that post-
natal LPS administration results in a chronic though mild
form of astrogliosis, a feature commonly found in a number
of seizure models (Somera-Molina et al., 2007; Oberheim
et al., 2008) and patients with epilepsy (Eid et al., 2008).
Although clinical and experimental evidence suggest that
infection or inﬂammation facilitates seizure predisposition
(Vezzani and Granata, 2005; Auvin et al., 2010; Vezzani and
Baram, 2007) the pathogenesis of GA-induced convulsive
Open accebehavior is still unknown. Therefore, we decided to inves-
tigate the involvement of proinﬂammatory cytokines during
critical periods of development (Galic et al., 2008) in elec-
troencephalographic and neurochemical alterations induced
by GA. For this purpose we investigated the effect of LPS
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dministration on seizures and alterations of striatal levels
f IL-1 induced by GA in rat pups (21 days-old).
xperimental procedures
nimal and reagents
wenty one days-old male Wistar rats (30—40 g), maintained
nder controlled light and environment (12:12 h light—dark cycle,
4± 1 ◦C, 55% relative humidity) with free access to food (Guabi,
anta Maria, Brazil) were used. Animal utilization protocols fol-
owed the Ofﬁcial Government Ethics guidelines and were approved
y the University Ethics Committee. All efforts were made to reduce
he number of animals used, as well as to minimize their suffering.
ll reagents were purchased from Sigma (St. Louis, MO).
urgical procedure and behavioral evaluation
he animals were anesthetized with ketamine—xylazine
45—9mg/kg body weight; i.p.) and placed in a rodent stereotaxic
pparatus. Under stereotaxic guidance, a cannula was inserted
nilaterally into the right striatum (coordinates relative to bregma:
P 0mm, ML 3.0mm, V 2.5mm from the dura). Chloramphenicol
200mg/kg) was administrated intraperitoneally (i.p.) immediately
efore the surgical procedure. The behavioral evaluation was
erformed 3 days after surgery when animals did not show any sign
f pain, infection or discomfort.
In order to determine the convulsant dose of GA in rat pups, the
nimals were injected with GA (0.13; 0.4 or 1.3mol/2l) or saline
1.3mol/2l) into the right striatum. Glutaric acid solutions were
eutralized with NaOH to pH 7.4 and injections were performed over
1min interval. Immediately after the intrastriatal injections, the
nimals were transferred to a round open ﬁeld (54.7 cm in diameter)
ith a ﬂoor divided into 10 equal areas. During 20min, the animals
ere videomonitored for the appearance of seizures. The latency
o clonic and generalized convulsions and time in seizures were
ecorded. Clonic convulsions were characterized by typical partial
lonic activity affecting the face, head, vibrissae and forelimbs.
eneralized convulsive episodes were characterized by generalized
hole-body clonus involving all four limbs and tail, rearing, wild
unning and jumping, sudden loss of upright posture and autonomic
igns, such as hypersalivation and defecation, respectively.
To investigate whether inﬂammation alters seizure activity
nduced by GA, LPS (2mg/kg; E. coli 055 B5; Eriksson et al., 2000;
aeda et al., 2008) or vehicle was infused i.p. (single adminis-
ration) 3 or 6 h before the administration of GA (0.13; 0.4 or
.3mol/site) or saline (1.3mol/site). The animals were then
ransferred to a round open ﬁeld and convulsive behavior was
valuated as described above. Immediately after the behavioral
er the Elsevier OA license.acilitated convulsions and increased IL-1 levels, we investi-
ated whether this cytokine is involved LPS-induced facilitation
f GA-induced seizures. The animals were subjected to intrastri-
tal injection of IL-1 antibody (200 ng/2l) or IL-1 denatured
ntibody 45min before injection of LPS (2mg/kg; i.p.) or vehicle
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2mg/kg, i.p.). This dose of IL-1 antibody was chosen because it
either caused seizures nor altered motor activity in a pilot exper-
ment. Six hours after LPS or vehicle injection, GA (0.13, 0.4 or
.3mol/site) or saline (1.3mol/site) was administrated and the
ppearance of seizures monitored for 20min by behavioral and elec-
roencephalographic recordings (EEG).
lacement of cannula and electrodes for EEG recordings
subset of animals (n = 5—6) was anesthetized with
etamine—xylazine and surgically implanted with a cannula
nd electrodes under stereotaxic guidance. The guide cannula
27 gauge) was glued to a multipin socket and inserted into the
ight striatum through a previously opened skull oriﬁce. One screw
lectrode was placed over the right parietal cortex (coordinates in
m: AP −4.5; ML 2.5; and V 2) along with a ground lead positioned
ver the nasal sinus. Bipolar nichrome wire Teﬂon-insulated
epth electrodes (100m) were implanted into the right striatum
coordinates in mm: AP 0; ML 3; V 2.5). The electrodes were
onnected to the multipin socket and, together with the injection
annula, were ﬁxed to the skull with dental acrylic cement.
lectroencephalographic recordings were performed 3 days after
he surgery.
ntrastriatal injection of drugs and EEG recording
he procedures for EEG recordings were carried out as previ-
usly described by Magni et al. (2007). Routinely, the animals
ere allowed to settle for habituation in a plexiglas cage
25 cm× 25 cm× 60 cm) for at least 20min. Baseline EEG record-
ngs were obtained 10min prior to drugs administration in order
o establish an adequate control brain electrical activity. The drug
njection protocol used in this set of experiments was the same used
n those experiments that evaluated the effect of LPS on GA-induced
ehavioral seizures, except that EEG was concomitantly recorded
sing digital encephalographic equipment (Neuromap EQSA260,
euromap LTDA, Brazil). During 20min the animals were videomon-
tored for the appearance of clonic or tonic seizures. The latency
o seizures and time in seizures were recorded.
EEG signals were ampliﬁed, ﬁltered (0.1—70.0Hz, bandpass),
igitalized (sampling rate 250Hz) and stored in a PC for off-line
nalysis, as described below.
EG analyses
eizures were deﬁned by the occurrence of episodes consisting of a
attern of continuous high-amplitude sharp spikes in low-frequency
hythmic spiking activity in ipsilateral striatum and cortex (≥2×
aseline amplitude, ≥5 s). Handling for drug injection caused arti-
acts in the EEG (Figs. 1, 3 and 7). However, rhythmic scratching of
he electrode headset by the animal rarely caused artifacts. These
ecordings were easily identiﬁed and discarded.
ectal temperature measurement
n order to investigate the effect of infection state on the basal rec-
al temperature (Tr) of 21-days old rats, vehicle or LPS was infused
ntraperitoneally and Tr changes were recorded every hour for 3 or
h, and expressed as absolute value.
Rectal temperature was measured with a lubricated thermocou-
le, which was inserted into the rectum of the animal, for 1min.
he probe was linked to a digital device, which displayed the tem-
erature at the tip of the probe with a 0.1 ◦C precision. The values
isplayed were manually recorded. In order to minimize the effects
f the stress associated with handling and injecting on rectal tem-
erature, all rats were habituated to the measuring procedure for
wo consecutive days. In these sessions, the animals were sub-
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ected to the same temperature measuring procedure described
bove.
L-1 immunoassay
he content of IL-1 was determined in injected striatum (right).
fter the behavioral evaluation of seizures, the injected stria-
um was dissected rapidly out at 4 ◦C and frozen at −70 ◦C. The
triatum was weighed and homogenized in a solution containing
ovine serum albumin (BSA 10mg/ml), EGTA (2mM), EDTA (2mM)
nd PMSF (0.2mM) in phosphate-buffered saline (PBS, pH 7.4)
sing a Potter homogenizer. The striatum homogenate was cen-
rifuged (3000× g for 10min) and cytokines were determined in
upernatant. Cytokine levels were measured using a commercially
vailable ELISA Kit from R&D Systems (Minneapolis, MN) using a
elective antibody against rat IL-1, according to the manufac-
urer’s protocol, and are expressed as pg/mg of protein (detection
imit: 4 ng/ml).
rotein determination
rotein content was measured colorimetrically by the method of
radford (1976) using bovine serum albumin (1mg/ml) as a stan-
ard.
tatistics
he behavioral data were analyzed by non-parametric test
Kruskal—Wallis analysis of variance). Data from IL-1 lev-
ls and rectal temperature measurements were analyzed by
two-way ANOVA. Post hoc analysis was carried out by the
tudent—Newman—Keuls test. P < 0.05 was considered signiﬁcant.
he Pearson’s correlation coefﬁcient was used for correlation anal-
ses.
esults
A-induced seizures
n the present study, the intrastiatal injection saline
1.3mol/site) and GA (0.13mol/site) did not induces
onvulsive behavior. On the other hand, statistical analysis
evealed that intrastriatal injection of GA (1.3mol/site)
ecreased the latency to the ﬁrst convulsive episode
164.88± 18.18 s; H(3) = 24.08, P < 0.01; Fig. 1F] and
ncreased time in seizures 40.88± 4.5 s; [H(3) = 25.58;
< 0.01; Fig. 1G] as compared to GA (0.4mol/site) group.
he EEG recordings conﬁrmed these behavioral alterations
licited by the intrastriatal injection of GA (Figs. 1A—D). The
lectroencephalographically recorded GA-induced seizures
ere behaviorally accompanied by clonus of the left fore-
imb and/or hind limb and head, rotational behavior and
ull lateralization toward the left side of the body. In addi-
ion, EEG recordings of the ispilateral striatum revealed that
he GA administration caused the appearance of an epilep-
ogenic focus in the injected striatum that spread to the
psilateral cortex. The EEG seizure activities were charac-
erized by the occurrence of multispikes and major seizure
ctivity. Multispikes correlated with myoclonic jerks, which
re characteristic of clonic convulsions. Generalized convul-
ions appeared in the electroencephalographic recordings as
he major seizure activity, and were characterized by 2—3Hz
igh-amplitude activity (Figs. 1D—E). The animals that were
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Figure 1 Representative electroencephalographic recordings: intrastriatal administration of saline (control; A), intrastriatal
administration of GA (0.13mol/site; B), (0.4mol/site; C), and (1.3mol/site; D) which were accompanied by pattern of contin-
uous high-amplitude sharp spikes in low-frequency rhythmic spiking activity in ipsilateral striatum and cortex. (E) The expanded
waveforms from box of the EEG recording in D. In all traces the arrowhead indicates the saline or GA intrastriatal administration;
the arrow indicates the EEG pattern associated with generalized seizures. Str, ipsilateral striatum; Ctx, ipsilateral cortex. Calibra-
tion bars, 100V and 15 s. Effect of intrastriatal injection of GA (0.13; 0.4; 1.3mol/site) on the ﬁrst convulsion latency (F) and
time in seizures (G) in rat pups. Data are median and interquartile range for n = 6—8 in each group.*P < 0.01 as compared to GA
(0.4mol/site) group; Kruskal—Wallis analysis of variance.
142
Figure 2 Effect of injection LPS (i.p.) 6 h before of the intras-
triatal administration of GA (0.13; 0.4; 1.3mol/site) on the
ﬁrst convulsion latency (A) and time in seizures (B) in rat pups.
Data are median and interquartile range for n = 6—8 in each
group. *P < 0.05 when compared to vehicle 6 h or LPS 6 h/GA
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decreased seizure latency and increased time in seizures. In0.4mol/site) groups (A, B); #P < 0.05 when compared to vehi-
le 6 h/GA (1.3mol/site) group (A, B); Kruskal—Wallis analysis
f variance.
njected with GA (1.3mol/site) showed 3.0± 0.55 seizures
uring the 20min period of observation.
PS facilitates GA-induced seizures
tatistical analysis revealed that administration of LPS 3 h
efore the intrastriatal injection of GA (all doses) had
o effect on the latency to convulsions [119.62± 53.61 s;
(7) = 5.46; P > 0.05] and time in seizures [28.75± 8.04 s;
(7) = 7.66; P > 0.05] as compared to vehicle 3 h/GA
1.3mol/site) group (data not shown). On the other
and, statistical analysis revealed that the administra-
ion of LPS 6 h before intrastriatal injection of GA
1.3mol/site), decreased the latency to convulsions
39.7± 6.69 s; H(7) = 66.54; P < 0.05; Fig. 2A], and increased
he time in seizures [80.7± 7.17 s; H(7) = 66.05; P < 0.05;
ig. 2B] as compared to vehicle 6 h/GA (1.3mol/site)
roup. Prior administration of LPS (2mg/kg) did not cause
ehavioral changes.
LPS (2mg/kg) injection did not affect baseline
248.21± 5.40V) or interictal mean amplitude, when
ompared with control group (234.88± 1.16V, n = 6—8 in
ach group; data not shown). EEG recordings showed that
nimals injected with LPS 3 h before GA injection (Fig. 3C)
id not present signiﬁcant alterations in EEG recordings
hen compared with the group that received LPS 6 h before
A injection (Fig. 3E). However, the injection of LPS 6 h
efore GA decreased the latency to seizures [38.55± 7.37 s;
(2) = 7.05; P < 0.05; Fig. 3G] and increased the time in
t
i
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eizures [67.33± 10.82 s; H(2) = 10.97; P < 0.05; Fig. 3H] as
ompared to vehicle/GA (1.3mol/site; Fig. 3A) and LPS
h/GA (1.3mol/site; Fig. 3C) groups. Furthermore, LPS
2mg/kg) injection did not alter the number of convulsive
pisodes induced by GA (1.3mol/site, data not shown).
o animals died due to GA-induced convulsions.
ffect of LPS on basal rectal temperature
PS causes an initial drop in basal temperature (1—2 h)
ollowed by a temperature increase in the coming hours
3—6 h). Statistical analysis (two-way ANOVA with repeated
easures) showed that LPS administration increased rec-
al temperature after a period of ∼3 h [F(5,100) = 7.64;
< 0.01; Fig. 4] when compared with vehicle/saline and
ehicle/GA (1.3mol/site) groups. Post hoc analysis (F test
or simple effect) revealed that the LPS-induced increase of
ectal temperature in 3 h persisted up to 6 h [F(3,20) = 64.4;
< 0.05] when compared with vehicle/saline and vehicle/GA
1.3mol/site) groups.
L-1 levels in the striatum
ince LPS injection increased the GA-induced convul-
ive behavior, we evaluated the effect of administrating
his toxin on IL-1 levels after GA (1.3mol/site) injec-
ion in the striatum of rat pups. Statistical analysis
howed that LPS administration increased IL-1 levels after
[F(3,11) = 11.49; P < 0.01; Fig. 5A] and 6 h [F(3,10) = 8.26;
< 0.01; Fig. 5B] in the injected striatum. Post hoc analysis
Student—Newman—Keuls test) revealed that this increase
as higher in 6[F(3,13) = 4.58; P < 0.03] than in 3 h.
Correlation analyses (Pearson’s correlation coefﬁcient)
evealed a strong positive correlation between time in
eizures induced by GA administration (1.3mol/site) and
triatal IL-1 levels (r = 0.922; P < 0.03; Fig. 6) in animals
njected with LPS (2mg/kg; i.p.).
L-1 antibody treatment
ig. 7G—H shows that injection of the IL-1 anti-
ody (200 ng/2l), 45min before LPS prevented the
ytokine-mediated reduction in the latency [187.44± 27.3 s;
(3) = 17.26; P < 0.05] and the total time increase of seizures
26.88± 1.9 s; H(3) = 20.43; P < 0.05] as compared to IL-
 denatured antibody/LPS 6 h/GA (1.3mol/site) group.
hus, the administration of IL-1 antibody inhibited the LPS-
ediated increase in the duration of GA-induced seizures.
hese results are in agreement with the view that inﬂamma-
ory process plays a role in GA-induced seizures (Fig. 7A—H).
iscussion
he dose—effect curve for GA revealed that the dose of
.3mol/site caused seizures in rat pups, measured ashis context, there is a signiﬁcant body of evidence suggest-
ng that GA accumulation may play a role in the convulsions
nd neurological impairment seen in patients with glutaric
cidemia (Lima et al., 1998; Kolker et al., 2002; Fighera
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Figure 3 Representative electroencephalographic recordings: (A) intrastriatal administration of GA (1.3mol/site); (B) expanded
waveforms from box of the EEG recording in A; (C) injection LPS (i.p.) 3 h before intrastriatal administration of GA (1.3mol/site);
(D) expanded waveforms from box of the EEG recording in C; (E) injection LPS (i.p.) 6 h before intrastriatal administration of
GA (1.3mol/site); (F) expanded waveforms from box of the EEG recording in E. All seizures were accompanied by pattern of
continuous high-amplitude sharp spikes in low-frequency rhythmic spiking activity in ipsilateral striatum and cortex. In all traces the
arrowhead indicates the GA intrastriatal administration; the arrow indicates the EEG pattern associated with generalized seizures.
Str, ipsilateral striatum; Ctx, ipsilateral cortex. Calibration bars, 100V and 15 s. Effect of injection LPS (3 or 6 h; i.p.) before of the
intrastriatal injection of GA (1.3mol/site) on the ﬁrst convulsion latency (G) and time in seizures (H) according EEG recordings.
Data are median and interquartile range for n = 6—8 in each group. *P < 0.05 when compared to vehicle/GA (1.3mol/site) group;
#P < 0.05 when compared to LPS 3 h/GA (1.3mol/site) group; Kruskal—Wallis analysis of variance.
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Figure 4 Effect of injection LPS (i.p.) following the intras-
triatal administration of saline or GA (1.3mol/site) on rectal
temperature from rat pups. Data are mean± S.E.M. from abso-
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Figure 6 Increase of time in seizures induced by LPS (i.p.) 6 h
before GA (1.3mol/site) correlates with increase IL-1 lev-
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Gute rectal temperatures for n = 6 in each group. *P < 0.01 as
ompared to control group and vehicle/GA (1.3mol/site)
roup. Two-way ANOVA (Student—Newman—Keuls test).
t al., 2006). Moreover, experimental ﬁndings in vivo and
n vitro suggest that energy metabolism impairment and
ecrease in the L-[3H] glutamate uptake play an important
ole in the convulsive behavior elicited by GA (Porciúncula
t al., 2004; Magni et al., 2009). In fact, an impairment of
lutamate metabolism and homeostasis has been proposed
o underlie several brain diseases, including epilepsy (Kelly
nd Stanley, 2001).Since patients with GA-I are more prone to seize when
resenting an infectious/inﬂammatory disease, we decided
o investigate whether LPS administration (3 h and 6 h before
A administration) facilitated the seizures induced by this
igure 5 Effect on the IL-1 levels after administration of LPS
3 h; A and 6 h; (B) in the GA-injected striatum (1.3mol/site)
rom rat pups. Data are mean± S.E.M from IL-1 levels for
= 4—5 in each group. *P < 0.01 as compared to control group
nd #P < 0.01 as compared to vehicle/GA (1.3mol/site) group
A, B); Two-way ANOVA (Student—Newman—Keuls test).
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tls in the striatum (Pearson’s correlation coefﬁcient). Data are
ndividual values for n = 6 in each group.
rganic acid. LPS injection 6 h before intrastriatal GA injec-
ion reduced seizure latency and increased time in seizures
hen compared with GA alone. In this context, it has
een shown that LPS administration enhances seizure sus-
eptibility in mice injected with PTZ. Interestingly, this
henomenon is blocked by antiinﬂammatory drugs (Sayyah
t al., 2003), suggesting the involvement of proinﬂammatory
olecules in LPS-induced seizure susceptibility. It is worth
oting that the facilitatory effect of LPS on GA-induced
eizures was seen only when LPS was administered 6 h before
A, but did not at 3 h.
In addition, the LPS-induced increase of rectal tempera-
ure at 3 h was of similar magnitude of that observed at 6 h,
ndicating that changes in GA-induced convulsive parame-
ers observed after LPS injection (at 6 h) is not related to an
ncrease in body temperature.
Since LPS is a general stimulator of innate immune sys-
em to produce proinﬂammatory and/or cytotoxic factors
s IL-1, IL-6, TNF- (Cohen, 2002), it has been used to
nduce neuroinﬂammation in animals (Eriksson et al., 2000;
liev et al., 2001; Turrin et al., 2001; Turrin and Rivest,
004; Maeda et al., 2008). Therefore, we determined the
L-1 levels in the GA-injected striatum at 3 and 6 h after
PS administration, and it observed that LPS treatment
ncreased IL-1 levels at 3 and 6 h in a time-dependent man-
er.
This study does not provide a mechanism by which
ncreased IL-1 levels facilitates GA-induced seizures in LPS-
njected animals. However, our results are in agreement
ith previous studies that have shown that cerebral IL-1
evels are signiﬁcantly higher in animals treated with LPS
nd kainic acid (KA) which developed seizures than in those
hat did not seize (Heida and Pittman, 2005). Thus, it is
lausible to propose that increased neuronal excitability
licited by higher striatal IL-1 level leads to appearance
f electroencephalographic and behavioral seizures induced
y administration of GA and LPS. In addition, we observed a
trong correlation between time in GA-induced seizures and
triatal IL-1 levels in LPS-injected animals (LPS injected 6 h
efore GA administration). Taken together these observa-
ions, we may suggest that there should be a higher striatal
L-1 level to generate neuronal excitability and to increase
he time in seizures as observed here.
In this context, it has been demonstrated that
dministration of IL-1 prolongs the duration of elec-
roencephalographic and behavioral seizures induced by
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Figure 7 Representative electroencephalographic recordings: (A) intrastriatal injection IL-1 denatured antibody 45min before
vehicle (i.p.) and 6 h before intrastriatal administration of GA (1.3mol/site); (B) expanded waveforms from box of the EEG
recording in A; (C) intrastriatal injection IL-1 denatured antibody 45min before injection LPS (i.p.) and 6 h before intrastriatal
administration of GA (1.3mol/site); (D) expanded waveforms from box of the EEG recording in C; (E) intrastriatal injection IL-1
antibody 45min before LPS (i.p.) and 6 h before intrastriatal administration of GA (1.3mol/site), which delayed the appearance of
pattern of continuous high-amplitude sharp spikes in low-frequency rhythmic spiking activity in ipsilateral striatum and cortex; (F)
expanded waveforms from box of the EEG recording in E. In all traces the arrowhead indicates the GA intrastriatal administration;
the arrow indicates the EEG pattern associated with generalized seizures. Str, ipsilateral striatum; Ctx, ipsilateral cortex. Calibration
bars, 100V and 15 s. Effect of IL-1 antibody on the ﬁrst convulsion latency (G) and time in seizures (H) in rat pups that received
LPS 6 h before GA (1.3mol/ striatum). Data are median and interquartile range for n = 6—8 in each group. *P < 0.05 as compared
to IL-1 denatured antibody/vehicle 6 h/GA (1.3mol/site) group (D, E) and #P < 0.05 as compared to IL-1 antibody/LPS 6 h/GA
(1.3mol/site) group (D, E); Kruskal—Wallis analysis of variance.
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ntracerebral application of KA in rodents (Vezzani et al.,
999). On the other hand, the intracerebral injection of
L-1-receptor antagonist (IL-1Ra) has powerful anticonvul-
ant effects (Vezzani et al., 2002), and transgenic mice
verexpressing IL-1Ra have a reduced susceptibility to
eizures (Vezzani et al., 2000), suggesting that cerebral IL-
 increase contributes to the maintenance of seizures in
hese models.
Current evidence indicates that cytokines, particularly
L-1, increase neuronal excitability by activating IL-1
eceptors (Vezzani et al., 1999; Bernardino et al., 2005).
n this context, it has been suggested that IL-1R1-mediated
odulation of glutamatergic transmission may contribute
o excitotoxicity and spontaneous seizures since IL-1R1 and
-methyl-D-aspartate (NMDA) receptors colocalize in the
triatum (Lawrence et al., 1998; Kwon et al., 2008) and
n hippocampal pyramidal neurons (Viviani et al., 2003). In
ddition, the neuronal IL-1R1 stimulation induces Src kinase-
ediated tyrosine phosphorylation of the NR2B subunit of
he NMDA receptor. As a consequence, IL-1 facilitates
MDA receptor-mediated Ca2+ inﬂux into neurons, promot-
ng excitotoxicity (Viviani et al., 2003) and, possibly, seizure
eneration (Vezzani and Baram, 2007). IL-1 can also inhibit
lutamate uptake in astrocytes (Hu et al., 2000) and increase
ts glial release possibly via TNF- production (Bezzi et al.,
001), thus resulting in elevated extracellular glutamate
evels and hyperexcitability. It is also worth pointing out
hat IL-1 has been shown to reduce -aminobutyric acid
GABA)A receptor-mediated chloride currents in hippocam-
al cell cultures (Wang et al., 2000), which may further
dd to seizure generation. Thus, since increased gluta-
atergic transmission and/or inhibited GABAergic function
ay induce seizures (Fighera et al., 2003, 2006), it is
lausible that the dual actions of IL-1 on excitatory and
nhibitory neurotransmission could facilitate GA-induced
eizures. However, this explanation remains speculative in
ature, and further studies are necessary to clarify this
oint.
Although the tissue concentrations of GA after intrastri-
tal administration are unknown, we may speculate that
eduction of glutamate uptake by GA may facilitate the
ctivation of excitatory amino acids receptors and, con-
equently, to generate seizures. Of note, it has been
hown that glutamate transporters inhibitors do not produce
eizures by themselves, but they are capable of facilitat-
ng seizures in the presence of inﬂammation (Liu et al.,
009). Since GA enhances synaptic turnover of glutamate
nd neuronal hyperexcitability (Nanitsos et al., 2004), it
s plausible to propose that LPS-induced increase in IL-1
evels facilitates seizures by increasing neuronal glutamate
vailability. Taken together these observations, and previ-
us reports demonstrating that GA inhibits glutamate uptake
Porciúncula et al., 2004) and that IL-1 may induce excito-
oxicity by glutamatergic mechanisms (Viviani et al., 2003;
ezzani and Baram, 2007), it is conceivable that our results
ay be related to these ﬁndings.
We also found that anti-IL-1 antibody prevented the IL--induced reduction of seizure latency and increase of time
n seizures, suggesting the participation of this proinﬂamma-
ory cytokine in the increased seizures susceptibility. These
ata suggest that IL-1 signaling present in inﬂammatory
rocess contributes critically to neuronal hyperexcitability
E
ED.V. Magni et al.
nd consequently in GA-induced reduction of seizure latency
nd increase of time in seizures. This ﬁnding is reinforced
y the evidence that impairment of the endogenous produc-
ion of IL-1 by using selective blockade, or gene knockout
f caspase-1, the enzyme producing the biologically active
orm of IL-1, signiﬁcantly reduces seizures (Ravizza et al.,
006).
In conclusion, since IL-1 can exacerbate seizures,
nhibit neurogenesis and increase blood—brain barrier per-
eability (Quagliarello et al., 1991; Ekdahl et al., 2003),
harmacologic approaches speciﬁcally targeted to block
he overproduction of IL-1 or its function(s) in glutaric
cidemia may represent new nonconventional strategies for
he treatment of seizure in this disorder. However, clinical
tudies shall be conducted in order to evaluate its clinical
fﬁcacy in glutaric acidemic patients.
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